These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32271423)

  • 21. GCNT2 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma cells.
    Peng F; He Q; Cheng C; Pan J
    Cell Biochem Funct; 2019 Jan; 37(1):42-51. PubMed ID: 30575058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of PLOD2 in esophageal squamous cell carcinoma and its correlation with invasion and metastasis].
    Di WY; Kang XH; Zhang JH; Wang Y; Kou WZ; Su W
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):102-107. PubMed ID: 30695860
    [No Abstract]   [Full Text] [Related]  

  • 23. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
    Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
    Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.
    Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L
    Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
    Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis.
    Li Z; Qin X; Bian W; Li Y; Shan B; Yao Z; Li S
    J Exp Clin Cancer Res; 2019 Nov; 38(1):477. PubMed ID: 31775815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA linc-UBC1 promotes tumor invasion and metastasis by regulating EZH2 and repressing E-cadherin in esophageal squamous cell carcinoma.
    Niu G; Zhuang H; Li B; Cao G
    J BUON; 2018; 23(1):157-162. PubMed ID: 29552776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma.
    Zeng B; Zhang X; Zhao J; Wei Z; Zhu H; Fu M; Zou D; Feng Y; Luo H; Lei Y
    BMC Cancer; 2019 Jun; 19(1):609. PubMed ID: 31226958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
    Zheng L; Zhao Z; Rong L; Xue L; Song Y
    J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-145 performs as a tumor suppressor in human esophageal squamous cell carcinoma by targeting phospholipase C epsilon 1.
    Tang C; He JY; Yu C; Wang PJ; Huang SH; Zheng HJ; Yan DQ; Zhang JH; Li Y
    J Cell Biochem; 2019 Jun; 120(6):10678-10687. PubMed ID: 30652343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-490-3p inhibited the proliferation and metastasis of esophageal squamous cell carcinoma by targeting HMGA2.
    Kang NN; Ge SL; Zhang RQ; Huang YL; Liu SD; Wu KM
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8298-8305. PubMed ID: 30556870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of lncRNA-HEIH curbs esophageal squamous cell carcinoma progression by modulating miR-4458/PBX3.
    Wang D; You D; Pan Y; Liu P
    Thorac Cancer; 2020 Jul; 11(7):1963-1971. PubMed ID: 32449803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells.
    Chai DM; Qin YZ; Wu SW; Ma L; Tan YY; Yong X; Wang XL; Wang ZP; Tao YS
    J Exp Clin Cancer Res; 2019 Feb; 38(1):102. PubMed ID: 30808397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
    Zhao Y; Wang Y; Xing G
    Biomed Pharmacother; 2018 Oct; 106():1650-1660. PubMed ID: 30119241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
    Feng Y; Yan S; Huang Y; Huang Q; Wang F; Lei Y
    BMC Cancer; 2020 Jun; 20(1):602. PubMed ID: 32600359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration.
    Xiao J; Yang W; Xu B; Zhu H; Zou J; Su C; Rong J; Wang T; Chen Z
    BMC Cancer; 2018 Oct; 18(1):976. PubMed ID: 30314454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-32 promotes esophageal squamous cell carcinoma metastasis by targeting CXXC5.
    Liu YT; Zong D; Jiang XS; Yin L; Wang LJ; Wang TT; Zhu J; He X
    J Cell Biochem; 2019 Apr; 120(4):6250-6263. PubMed ID: 30362164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocadherin 8 (PCDH8) Inhibits Proliferation, Migration, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma.
    Yu H; Jiang X; Jiang L; Zhou H; Bao J; Zhu X; Liu F; Huang J
    Med Sci Monit; 2020 Apr; 26():e920665. PubMed ID: 32330123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
    He SL; Wang WP; Yang YS; Li EM; Xu LY; Chen LQ
    J Cell Mol Med; 2019 Feb; 23(2):1375-1385. PubMed ID: 30565387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.